Bio-Rad Laboratories (BIO) FCF Margin (2009 - 2026)
Bio-Rad Laboratories (BIO) posted quarterly FCF Margin of 13.19% for Q1 2026, down 312.0% year-over-year from 6.22% in Q1 2025, and down 23.23% quarter-over-quarter from 17.18% in Q4 2025.
Bio-Rad Laboratories (BIO) FCF Margin (2009 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO) has reported FCF Margin for 18 consecutive years, with 13.19% the latest figure, recorded in Q1 2026.
- In Q1 2026, FCF Margin fell 312.0% year-over-year to 13.19%; the TTM figure through Mar 2026 stood at 13.79% (down 20.0% YoY), while the FY2025 annual figure was 14.5%, up 322.0% from the prior year.
- FCF Margin eased to 13.19% in Q1 2026 per BIO's latest filing, from 17.18% in the prior quarter.
- Across five years, FCF Margin topped out at 18.99% in Q3 2024 and bottomed at 2.44% in Q3 2022.
- Historically, FCF Margin has averaged 9.41% across 5 years, with a median of 9.22% in 2023.
- Annual changes were most pronounced in 2022 — FCF Margin sank 2864 bps — and 2025, when it jumped 1147 bps.
- Bio-Rad Laboratories' FCF Margin stood at 6.13% in 2022, then declined by 7 bps to 5.69% in 2023, then soared by 114 bps to 12.18% in 2024, then surged by 41 bps to 17.18% in 2025, then slipped by 23 bps to 13.19% in 2026.
- Business Quant data shows BIO's FCF Margin at 13.19% in Q1 2026, 17.18% in Q4 2025, and 13.66% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 15.81% |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 16.07% |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 23.50% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 33.60% |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 14.10% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 1.28% |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 5.32% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 18.73% |
| 10 | Bio-Rad Laboratories | 10.09 Bn | 8.47 Bn | 345.80 Mn | 10.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.25% |
| Mar 31, 2026 | 13.19% |
| Dec 31, 2025 | 17.18% |
| Sep 30, 2025 | 13.66% |
| Jun 30, 2025 | 10.87% |
| Mar 31, 2025 | 16.31% |
| Dec 31, 2024 | 12.18% |
| Sep 30, 2024 | 18.99% |
| Jun 30, 2024 | 8.66% |
| Mar 31, 2024 | 4.85% |
| Dec 31, 2023 | 5.69% |
| Sep 30, 2023 | 8.48% |
| Jun 30, 2023 | 9.31% |
| Mar 31, 2023 | 9.22% |
| Dec 31, 2022 | 6.13% |
| Sep 30, 2022 | -2.44% |
| Jun 30, 2022 | 5.21% |
| Mar 31, 2022 | 2.49% |
| Dec 31, 2021 | 15.66% |
| Sep 30, 2021 | 26.20% |